FDA Inspection
Alora PharmaceuticalsAlora Pharmaceuticals – FDA Inspection, Apr 13, 2026
Record Details
This FDA Inspection record concerns Alora Pharmaceuticals, with an inspection on April 13, 2026, issued by the Atlanta District Office, covering human drugs.
View Company Profile
ID · 38a374e9-b736-4d83-9e61-6551e192e337
Inspection Facts
- Inspection number
- 1312272
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.166(a)Written program not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Alora Pharmaceuticals
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 29, 2019 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 21, 2017 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| September 11, 2017 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| March 8, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Alora Pharmaceuticals
- FDA Inspection 1085822 - 2019-03-29
- FDA Inspection 1048852 - 2017-12-21
- FDA Inspection 1028389 - 2017-09-11
- FDA Inspection 1014708 - 2017-03-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.